Back to search
FDAFDA · Food and drugs·Recall number D-838-2013

Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-053-10

Published August 14, 2013 · Recall initiated: May 13, 2013

Summary

FDA records drug Class I recall D-838-2013, published August 14, 2013 and initiated May 13, 2013. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 960 Bottles; Lot: Lot MM5767. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zydus Pharmaceuticals USA Inc
Distributor
Nationwide
Lot
Lot MM5767
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-053-10 recalled?

Yes. FDA published recall D-838-2013 on August 14, 2013. Reported hazard: Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.

What should I do if I have this product?

Voluntary: Firm initiated · Letter